Legend Biotech (LEGN) Interest Expenses (2019 - 2025)
Historic Interest Expenses for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$5.6 million.
- Legend Biotech's Interest Expenses fell 239.83% to -$5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.9 million, marking a year-over-year decrease of 18854.27%. This contributed to the annual value of -$21615.0 for FY2024, which is 82.13% up from last year.
- Per Legend Biotech's latest filing, its Interest Expenses stood at -$5.6 million for Q3 2025, which was down 239.83% from -$5.2 million recorded in Q2 2025.
- Legend Biotech's 5-year Interest Expenses high stood at $5.5 million for Q1 2024, and its period low was -$5.7 million during Q3 2023.
- Moreover, its 5-year median value for Interest Expenses was -$1.6 million (2022), whereas its average is -$1.9 million.
- Data for Legend Biotech's Interest Expenses shows a peak YoY increase of 251578.95% (in 2022) and a maximum YoY decrease of 305961.54% (in 2022) over the last 5 years.
- Over the past 5 years, Legend Biotech's Interest Expenses (Quarter) stood at -$602000.0 in 2021, then crashed by 707.48% to -$4.9 million in 2022, then surged by 99.88% to -$5820.0 in 2023, then increased by 11.48% to -$5152.0 in 2024, then crashed by 109294.41% to -$5.6 million in 2025.
- Its last three reported values are -$5.6 million in Q3 2025, -$5.2 million for Q2 2025, and -$5.1 million during Q1 2025.